Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma

Background: Glioblastoma (GBM) is the most lethal cancer of the central nervous system. Integrin beta 5 (ITGB5) is thought to be involved in intercellular signal transduction and regulation of tumor initiation and progression. However, the function of ITGB5 in GBM is not known. Methods: To address t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu-yang, Guo, Qing, Guan, Ge-fei, Cheng, Wen, Cheng, Peng, Wu, An-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764112/
https://www.ncbi.nlm.nih.gov/pubmed/31616629
http://dx.doi.org/10.3389/fonc.2019.00904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764112/
https://www.ncbi.nlm.nih.gov/pubmed/31616629
http://dx.doi.org/10.3389/fonc.2019.00904

Ejemplares similares